<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-127217" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Nuclear Medicine Test</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goldenhart</surname>
            <given-names>Alyssa L.</given-names>
          </name>
          <aff>Nova Southeastern University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Senthilkumaran</surname>
            <given-names>S</given-names>
          </name>
          <aff>Department of Emergency Medicine and Critical Care, Manian Medical Centre, Erode, India</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Alyssa Goldenhart declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>S Senthilkumaran declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>12</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-127217.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Nuclear medicine is conducted by administering small doses of radioactive material to a patient and then using a device, gamma camera, to detect the location of the material. A variety of radiotracers can be given to a patient through injection, inhalation, or ingestion. The most commonly used radiotracers include indium-111, technetium-99m, gallium-67, and fluorodeoxyglucose. All of these materials emit gamma radiation, which is picked up by an imaging device to determine a specific function of the patient&#x02019;s body.<xref ref-type="bibr" rid="article-127217.r1">[1]</xref><xref ref-type="bibr" rid="article-127217.r2">[2]</xref>&#x000a0;Depending on which radiotracer is used, the radioactive material is eliminated from the patient&#x02019;s body by the lungs, urine, or stool within hours to days.<xref ref-type="bibr" rid="article-127217.r3">[3]</xref>&#x000a0;</p>
        <p>The process of administering radiotracers to the patient instead of from an external source is called endoradiology. Nuclear medicine differs from other imaging studies because it can show the body's anatomic structures and the organs' function. It can even show processes down to the molecular and cellular level, such as blood flow, cellular metabolism, expression of cell receptors, and more.<xref ref-type="bibr" rid="article-127217.r1">[1]</xref><xref ref-type="bibr" rid="article-127217.r2">[2]</xref><xref ref-type="bibr" rid="article-127217.r4">[4]</xref></p>
      </sec>
      <sec id="article-127217.s2" sec-type="Specimen Collection">
        <title>Specimen Collection</title>
        <p>Various specimens may need to be collected for nuclear medicine scans. In vitro methods for blood samples include drawing blood from the patient, commonly in the arm. The blood is then mixed with the appropriate radiotracer. Depending on the radiotracer, information can be obtained from the blood sample, or the sample needs to be injected back into the patient.<xref ref-type="bibr" rid="article-127217.r1">[1]</xref> The most common use of in vitro blood samples is determining red blood cell mass.</p>
        <p>Another common use of in vitro nuclear medicine includes a urea breath test. A patient ingests a radiotracer pill and breathes through a straw into a balloon to capture air from the lungs. The air is then assessed for increased labeled 14CO2 in the patient&#x02019;s breath.<xref ref-type="bibr" rid="article-127217.r5">[5]</xref></p>
        <p>There are less common uses of in vitro nuclear medicine. Some of these processes include the need to collect fluid and tissue samples. Any specimen collection must be completed through a sterile process.</p>
      </sec>
      <sec id="article-127217.s3" sec-type="Procedures">
        <title>Procedures</title>
        <p>The most common uses for nuclear medicine include examining the kidneys, thyroid, heart, brain, bones, and breasts. Procedures can be broken down into in vivo and in vitro studies. In vitro studies are less common and include taking a sample from the patient, most commonly a blood sample, and assessing it through nuclear medicine outside the patient&#x02019;s body. In&#x000a0;vivo methods are more commonly used. In these studies, radiotracer material is given to the patient through injection, consumption, or inhalation, depending on the specific type of study. After administration of the radioactive material, a gamma camera takes photographs of the patient.</p>
        <p>The images can either be two or three-dimensional. Two-dimensional images are obtained from a stationary gamma camera. Three-dimensional images are produced through single-photon emission computed tomography (SPECT) or Positron Emission Tomography (PET). SPECT uses a gamma camera that rotates around the patient to create a three-dimensional image.&#x000a0; PET uses the radioisotope fluorine-18, which releases positrons captured by the camera. This image has better spatial resolution and contrast. The images are compared to evaluate the activity at the organ, tissue, or cell level.<xref ref-type="bibr" rid="article-127217.r4">[4]</xref></p>
      </sec>
      <sec id="article-127217.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Indications for nuclear medicine include assessing organs' function, detecting cancers, and identifying rejection of a transplant, diagnosis, or treatment.</p>
        <p>
<bold>Common indications include:</bold>
</p>
        <p>
<bold>Heart</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Visualize myocardial perfusion</p>
          </list-item>
          <list-item>
            <p>Assess cardiac function</p>
          </list-item>
          <list-item>
            <p>Calculate the ejection fraction</p>
          </list-item>
        </list>
        <p>
<bold>Lungs</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Evaluate lung perfusion</p>
          </list-item>
          <list-item>
            <p>Assess lung function</p>
          </list-item>
          <list-item>
            <p>Diagnose a pulmonary embolism</p>
          </list-item>
        </list>
        <p>
<bold>Genitourinary</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Evaluate renal perfusion</p>
          </list-item>
          <list-item>
            <p>Detect renal obstructions</p>
          </list-item>
          <list-item>
            <p>Discover vesicourethral reflux</p>
          </list-item>
        </list>
        <p>
<bold>Bones</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Detect diseases such as osteomyelitis or Paget&#x02019;s disease</p>
          </list-item>
          <list-item>
            <p>Evaluate spondylolisthesis</p>
          </list-item>
          <list-item>
            <p>Evaluate osteopathies such as fractures</p>
          </list-item>
        </list>
        <p>
<bold>Thyroid</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Determine thyroid size</p>
          </list-item>
          <list-item>
            <p>Treat hyperthyroidism</p>
          </list-item>
          <list-item>
            <p>Detect hypothyroidism</p>
          </list-item>
          <list-item>
            <p>Locate ectopic thyroid tissue</p>
          </list-item>
        </list>
        <p>
<bold>Gastrointestinal</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Determine the gastric emptying time to detect anatomical obstruction or delayed emptying time</p>
          </list-item>
          <list-item>
            <p>Evaluate esophageal motility</p>
          </list-item>
          <list-item>
            <p>Identify&#x000a0;a gastrointestinal bleed</p>
          </list-item>
          <list-item>
            <p>Locate Meckel&#x02019;s diverticulum</p>
          </list-item>
          <list-item>
            <p>Detect hepatic lesions</p>
          </list-item>
        </list>
        <p>
<bold>Brain</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Evaluate blood flow to the brain</p>
          </list-item>
          <list-item>
            <p>Follow up on the response to treatment for infection</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-127217.s5" sec-type="Potential Diagnosis">
        <title>Potential Diagnosis</title>
        <p>Cancers can be diagnosed and staged by nuclear medicine scans. Cancer cells uptake more glucose than normal cells. Thus, when fluorine-18-fluorodeoxyglucose is given to a patient, it accumulates in cancer cells. The limitations of this include organs that have lower metabolic activities, such as the prostate and liver. This has led to the creation of the radiotracers carbon-11 methyl-methionine, fluorine-18-fluoro-l-phenylalanine, and fluorine-18-fluoro-L-thymidine, which detect DNA synthesis and metabolism of amino acids. These can help detect cancers not as well detected by fluorine-18-fluorodeoxyglucose, such as cancers in the brain.<xref ref-type="bibr" rid="article-127217.r4">[4]</xref></p>
        <p>Nuclear medicine can also be used to detect inflammation and infection. The radiotracers indium-111 and technetium-99m are tagged onto a patient&#x02019;s white blood cells. The mixture of tagged white blood cells is injected back into the patient, and these white blood cells travel to areas of inflammation and infection. A scintillation camera detects which areas the white blood cells travel to, indicating infection. Other ways to detect infection include using nanomaterials that target monocytes and macrophages. The phagocytic properties of these cells allow them to uptake the nanoparticles. Increased activity is shown in areas where there is increased uptake of the nanoparticles.<xref ref-type="bibr" rid="article-127217.r1">[1]</xref><xref ref-type="bibr" rid="article-127217.r6">[6]</xref>&#x000a0;</p>
        <p>Decreased glucose uptake in certain parts of brain tissue is seen in neurodegenerative disorders. Scanning the brain after injection of fluorine-18-fluorodeoxyglucose allows one to see the brain's glucose metabolism. In healthy individuals, the entire cerebral cortex shows glucose metabolism. Patients with Alzheimer&#x02019;s disease shows decreased glucose metabolism in certain parts of the brain.<xref ref-type="bibr" rid="article-127217.r4">[4]</xref></p>
        <p>Radiotracers can diagnose perfusion deficits. A patient&#x02019;s red blood cells are tagged with radiotracers and injected back into the bloodstream. Detecting where the blood cells go, and their movement pattern can diagnose coronary artery disease. This is not limited to the heart. Other organs, such as the kidneys, gastrointestinal tract, and lungs, can all have perfusion assessed via nuclear medicine.<xref ref-type="bibr" rid="article-127217.r7">[7]</xref>&#x000a0;</p>
        <p>Nuclear medicine shows promise with the diagnosis of coronary atherosclerosis. A&#x000a0;few studies have shown that fluorine-18-fluorodeoxyglucose has increased uptake in areas of atherosclerotic lesions, such as in the carotid arteries.<xref ref-type="bibr" rid="article-127217.r7">[7]</xref><xref ref-type="bibr" rid="article-127217.r8">[8]</xref></p>
        <p>Gastrointestinal functionality can be assessed by nuclear medicine. Radiotracers are mixed into liquid egg whites and cooked to an omelet consistency. The patient eats this, and a gamma camera captures the movement of the food.<xref ref-type="bibr" rid="article-127217.r9">[9]</xref><xref ref-type="bibr" rid="article-127217.r10">[10]</xref>&#x000a0;</p>
        <p>Other diagnoses can be made about endocrine functionality, such as assessing thyroid functionality. A radioactive iodine uptake test using I-123 or I-131 is given to the patient, and the thyroid function is assessed to give the patient a diagnosis of hyperthyroidism.<xref ref-type="bibr" rid="article-127217.r11">[11]</xref></p>
      </sec>
      <sec id="article-127217.s6" sec-type="Normal and Critical Findings">
        <title>Normal and Critical Findings</title>
        <p>Depending on the study chosen, there are different normal and critical findings found in nuclear medicine. Normal findings arise when radiotracer is injected and interacts with the body in a predictable pattern. For example, in a bone scan, the radiotracer's uptake into bones should be symmetrical throughout the skeleton, with exceptions in the acromioclavicular joints and sacroiliac joints; a slight increase in uptake should be expected.<xref ref-type="bibr" rid="article-127217.r12">[12]</xref>&#x000a0;Critical findings arise when the radiotracer does not behave in the expected fashion. It is important to know the different possible results of the study in order to interpret the findings accurately.</p>
      </sec>
      <sec id="article-127217.s7" sec-type="Interfering Factors">
        <title>Interfering Factors</title>
        <p>SPECT imaging can produce false results from an assortment of imaging artifacts. These include movement from the patient, cardiac motion, attenuation of photon beams, and misalignment of the attenuation maps. The software has been developed to help diminish the effect of these artifacts. Some clinicians repeat the study with the patient positioned prone, supine, or standing to recognize artifacts better.<xref ref-type="bibr" rid="article-127217.r13">[13]</xref></p>
        <p>Other interfering factors can include improper elimination of the radiotracer. Some studies require that once the radiotracer is given, it is bound to the appropriate site, and the rest is eliminated via the kidneys or liver. If there is improper elimination, the radiotracer can be picked up in areas that obscure the results.<xref ref-type="bibr" rid="article-127217.r14">[14]</xref><xref ref-type="bibr" rid="article-127217.r3">[3]</xref></p>
        <p>Tc99m labeled radiotracers have the unique interfering factor of unbending, resulting in unbound Tc99m-pertechnetate. The free Tc99m travels around the patient&#x02019;s body and eventually localizes to the salivary glands, thyroid, and stomach. This may skew the interpretation of studies using this radiotracer.<xref ref-type="bibr" rid="article-127217.r12">[12]</xref><xref ref-type="bibr" rid="article-127217.r15">[15]</xref></p>
        <p>Studies requiring the detection of radiotracers inside patients can be obscured if the patient is wearing jewelry. It is recommended that all jewelry be removed before the procedure.</p>
        <p>Medications can also interfere with the results. Depending on the study being performed, it may be recommended that certain medications be held. For example, for radioactive iodine I-131&#x000a0;therapy, it is recommended that the patient does not take anti-thyroid medication such as propylthiouracil or methimazole one to two weeks before the procedure.<xref ref-type="bibr" rid="article-127217.r16">[16]</xref></p>
      </sec>
      <sec id="article-127217.s8" sec-type="Complications">
        <title>Complications</title>
        <p>Nuclear medicine procedures are generally considered safe. The most common risk factors include an allergic reaction to the radiotracer or an injection site reaction.</p>
        <p>Complications could include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Incomplete administration of the radiotracer:</bold> Either from not injecting, eating, or inhaling enough of the radiotracer</p>
          </list-item>
          <list-item>
            <p><bold>Diabetic hyperglycemia over 250 mg/dL:</bold> This can cause incomplete results for studies requiring ingestion of the radiotracer.<xref ref-type="bibr" rid="article-127217.r10">[10]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Glove phenomenon:</bold>&#x000a0;Contrast for a bone-imaging agent is injected into the radial artery; the bones take up more radiotracer in the palm and thumb due to blood flow.<xref ref-type="bibr" rid="article-127217.r17">[17]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Urinary tract infection:</bold>&#x000a0;After performing a retrograde radionuclide cystography<xref ref-type="bibr" rid="article-127217.r18">[18]</xref></p>
          </list-item>
        </list>
        <p>Side effects of nuclear medicine studies include:</p>
        <list list-type="bullet">
          <list-item>
            <p>An allergic reaction to the food when eating a meal containing the radiotracer, such as egg whites</p>
          </list-item>
          <list-item>
            <p>It is rare to have an adverse reaction to radiotracers. If a reaction does occur, it is most commonly a mild rash. A study found that an adverse reaction to radiotracers during 783,525 administrations only occurred in 0.0023% of participants.<xref ref-type="bibr" rid="article-127217.r19">[19]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-127217.s9" sec-type="Patient Safety and Education">
        <title>Patient Safety and Education</title>
        <p>It is important that before any nuclear medicine study is conducted, patients are educated on the procedure, the risks involved, and the preparation needed for the study. Nuclear medicine uses ionizing radiation from the radiotracers administered to the patient. The radiation a patient receives depends on the study being conducted and what radiotracer is injected. The dose is considered trivial if the effective radiation dose is &#x0003c;0.1 mSv. This includes studies of glomerular filtration rate, which use about .006 mSv of radiation. Studies like thyroid scans use about 0.14 mSv and are considered intermediate since the radiation dose is between 0.1 and 1 mSv. A dose between 1 and 10 mSv is considered intermediate. A nuclear bone scan uses about 4 mSv, placing it in the intermediate range.<xref ref-type="bibr" rid="article-127217.r12">[12]</xref>&#x000a0;</p>
        <p>Any dose of radiation above 10 mSv is considered moderate. Many therapeutic nuclear medicine procedures are in this category. For reference, the average amount of radiation an average person receives daily is about 3 mSv.<xref ref-type="bibr" rid="article-127217.r20">[20]</xref><xref ref-type="bibr" rid="article-127217.r21">[21]</xref></p>
        <p>Adverse effects of radiotracers are very uncommon. One study found that out of 783,525 radiotracer injections, only 18 patients had an adverse reaction to the radiotracer. This equates to an incidence of 0.0023%.<xref ref-type="bibr" rid="article-127217.r19">[19]</xref></p>
        <p>Many studies can be used for nuclear medicine, and patient education differs depending on the type that needs to be completed. Common topics to educate patients on include avoiding taking certain medications. For some studies, patients should avoid consuming carbonated drinks before the procedure.<xref ref-type="bibr" rid="article-127217.r22">[22]</xref> Other studies may require patients to avoid smoking. Breastfeeding women may need to avoid feeding for 12 to 24 hours, depending on the radiotracer.<xref ref-type="bibr" rid="article-127217.r12">[12]</xref></p>
      </sec>
      <sec id="article-127217.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>While many tools are used to evaluate a patient's anatomy, fewer are used to assess&#x000a0;physiological function. Nuclear medicine can do both. While the images captured from nuclear medicine might not be as high of a resolution as images from computed tomography or magnetic resonance&#x000a0;imaging, they can still be more sensitive for some indications. There is a wide range of uses for nuclear medicine, and new radiotracers are continually being developed. This presents a challenge to clinicians when sending patients for testing. Many patients who would benefit from these studies are not referred to have the study completed due to a clinician's lack of knowledge about the procedures.<xref ref-type="bibr" rid="article-127217.r23">[23]</xref>&#x000a0;</p>
        <p>Nuclear medicine has effective uses for myocardial perfusion imaging, detecting bone malignancies, detecting renal outflow obstruction, assessing thyroid nodules, detecting pulmonary embolisms, and more. Due to the nature of nuclear medicine, it can even be used to treat disorders such as hyperthyroidism and neural crest tumors.<xref ref-type="bibr" rid="article-127217.r16">[16]</xref><xref ref-type="bibr" rid="article-127217.r23">[23]</xref></p>
      </sec>
      <sec id="article-127217.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=127217&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=127217">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/127217/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=127217">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-127217.s12">
        <title>References</title>
        <ref id="article-127217.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sureshkumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ersahin</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Role of Nuclear Medicine in Imaging.</article-title>
            <source>Semin Ultrasound CT MR</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>10</fpage>
            <page-range>10-19</page-range>
            <pub-id pub-id-type="pmid">31964489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ell</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Nuclear medicine.</article-title>
            <source>Postgrad Med J</source>
            <year>1992</year>
            <month>Feb</month>
            <volume>68</volume>
            <issue>796</issue>
            <fpage>82</fpage>
            <page-range>82-105</page-range>
            <pub-id pub-id-type="pmid">1570267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications.</article-title>
            <source>J Nucl Med</source>
            <year>2014</year>
            <month>May</month>
            <volume>55</volume>
            <issue>5</issue>
            <fpage>786</fpage>
            <page-range>786-98</page-range>
            <pub-id pub-id-type="pmid">24591488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r4">
          <label>4</label>
          <element-citation publication-type="book">
            <collab>National Research Council (US) and Institute of Medicine (US) Committee on State of the Science of Nuclear Medicine</collab>
            <source>Advancing Nuclear Medicine Through Innovation</source>
            <publisher-name>National Academies Press (US)</publisher-name>
            <publisher-loc>Washington (DC)</publisher-loc>
            <year>2007</year>
            <pub-id pub-id-type="pmid">20669430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Peeters</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Urea breath test: a diagnostic tool in the management of Helicobacter pylori-related gastrointestinal diseases.</article-title>
            <source>Acta Gastroenterol Belg</source>
            <year>1998</year>
            <season>Jul-Sep</season>
            <volume>61</volume>
            <issue>3</issue>
            <fpage>332</fpage>
            <page-range>332-5</page-range>
            <pub-id pub-id-type="pmid">9795467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hammoud</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Molecular Imaging of Inflammation: Current Status.</article-title>
            <source>J Nucl Med</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>57</volume>
            <issue>8</issue>
            <fpage>1161</fpage>
            <page-range>1161-5</page-range>
            <pub-id pub-id-type="pmid">27173159</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tawakol</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Migrino</surname>
                <given-names>RQ</given-names>
              </name>
              <name>
                <surname>Bashian</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Bedri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vermylen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cury</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Yates</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>LaMuraglia</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Furie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Houser</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gewirtz</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Muller</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Brady</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Fischman</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2006</year>
            <month>Nov</month>
            <day>07</day>
            <volume>48</volume>
            <issue>9</issue>
            <fpage>1818</fpage>
            <page-range>1818-24</page-range>
            <pub-id pub-id-type="pmid">17084256</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunphy</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Freiman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Larson</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Strauss</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Association of vascular 18F-FDG uptake with vascular calcification.</article-title>
            <source>J Nucl Med</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>46</volume>
            <issue>8</issue>
            <fpage>1278</fpage>
            <page-range>1278-84</page-range>
            <pub-id pub-id-type="pmid">16085583</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Odunsi</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Camilleri</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Selected interventions in nuclear medicine: gastrointestinal motor functions.</article-title>
            <source>Semin Nucl Med</source>
            <year>2009</year>
            <month>May</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>186</fpage>
            <page-range>186-94</page-range>
            <pub-id pub-id-type="pmid">19341838</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Donohoe</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Maurer</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Ziessman</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Urbain</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Royal</surname>
                <given-names>HD</given-names>
              </name>
              <name>
                <surname>Martin-Comin</surname>
                <given-names>J</given-names>
              </name>
              <collab>Society for Nuclear Medicine</collab>
              <collab>American Neurogastroenterology and Motility Society</collab>
            </person-group>
            <article-title>Procedure guideline for adult solid-meal gastric-emptying study 3.0.</article-title>
            <source>J Nucl Med Technol</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>196</fpage>
            <page-range>196-200</page-range>
            <pub-id pub-id-type="pmid">19692450</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r11">
          <label>11</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mathew</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kaur</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rawla</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <chapter-title>Hyperthyroidism</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>3</month>
            <day>19</day>
            <pub-id pub-id-type="pmid">30725738</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r12">
          <label>12</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Adams</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Banks</surname>
                <given-names>KP</given-names>
              </name>
            </person-group>
            <chapter-title>Bone Scan</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>14</day>
            <pub-id pub-id-type="pmid">30285381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Slomka</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Berman</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Germano</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Quantitative analysis of perfusion studies: strengths and pitfalls.</article-title>
            <source>J Nucl Cardiol</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>338</fpage>
            <page-range>338-46</page-range>
            <pub-id pub-id-type="pmid">22302181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r14">
          <label>14</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Kaller</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>An</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <chapter-title>Contrast Agent Toxicity</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">30725844</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Loken</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Telander</surname>
                <given-names>GT</given-names>
              </name>
              <name>
                <surname>Salmon</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Technetium 99m compounds for visualization of body organs.</article-title>
            <source>JAMA</source>
            <year>1965</year>
            <month>Oct</month>
            <day>11</day>
            <volume>194</volume>
            <issue>2</issue>
            <fpage>152</fpage>
            <page-range>152-6</page-range>
            <pub-id pub-id-type="pmid">5897318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mumtaz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Hui</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Mohd Khir</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Radioiodine I-131 for the therapy of graves' disease.</article-title>
            <source>Malays J Med Sci</source>
            <year>2009</year>
            <month>Jan</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-33</page-range>
            <pub-id pub-id-type="pmid">22589645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shih</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Wienrzbinski</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ryo</surname>
                <given-names>UY</given-names>
              </name>
            </person-group>
            <article-title>Abnormally increased uptake in the palm and the thumb as the result of a bone imaging agent injection into the radial artery.</article-title>
            <source>Clin Nucl Med</source>
            <year>2000</year>
            <month>Jul</month>
            <volume>25</volume>
            <issue>7</issue>
            <fpage>539</fpage>
            <page-range>539-40</page-range>
            <pub-id pub-id-type="pmid">10885697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Malhotra</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Shannon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jacobson</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rigsby</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Holl</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>EY</given-names>
              </name>
            </person-group>
            <article-title>Urinary tract infection after voiding cystourethrogram.</article-title>
            <source>J Pediatr Urol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>13</volume>
            <issue>4</issue>
            <fpage>384.e1</fpage>
            <page-range>384.e1-384.e7</page-range>
            <pub-id pub-id-type="pmid">28579135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silberstein</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine.</article-title>
            <source>J Nucl Med</source>
            <year>1996</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>185</fpage>
            <page-range>185-92</page-range>
            <pub-id pub-id-type="pmid">8543992</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pandit</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vinjamuri</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Communication of radiation risk in nuclear medicine: Are we saying the right thing?</article-title>
            <source>Indian J Nucl Med</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>131</fpage>
            <page-range>131-4</page-range>
            <pub-id pub-id-type="pmid">25210276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <article-title>Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. Administration of Radioactive Substances Advisory Committee.</article-title>
            <source>Nucl Med Commun</source>
            <year>2000</year>
            <month>Jan</month>
            <volume>21 Suppl</volume>
            <fpage>S1</fpage>
            <page-range>S1-93</page-range>
            <pub-id pub-id-type="pmid">10732169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r22">
          <label>22</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Gopal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <chapter-title>Nuclear Medicine Stress Test</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>24</day>
            <pub-id pub-id-type="pmid">32491614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-127217.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prvulovich</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Bomanji</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <article-title>The role of nuclear medicine in clinical investigation.</article-title>
            <source>BMJ</source>
            <year>1998</year>
            <month>Apr</month>
            <day>11</day>
            <volume>316</volume>
            <issue>7138</issue>
            <fpage>1140</fpage>
            <page-range>1140-6</page-range>
            <pub-id pub-id-type="pmid">9552956</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
